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Abstract
Genome-wide association studies and meta-analysis indicate that several genes/loci are consistently associated with
rheumatoid arthritis (RA) in European and Asian populations. To evaluate the transferability status of these findings to an
ethnically diverse north Indian population, we performed a replication analysis. We investigated the association of 47 single-
nucleotide polymorphisms (SNPs) at 43 of these genes/loci with RA in a north Indian cohort comprising 983 RA cases and
1007 age and gender matched controls. Genotyping was done using Infinium human 660w-quad. Association analysis by
chi-square test implemented in plink was carried out in two steps. Firstly, association of the index or surrogate SNP (r2.0.8,
calculated from reference GIH Hap-Map population) was tested. In the second step, evidence for allelic/locus heterogeneity
at aforementioned genes/loci was assessed for by testing additional flanking SNPs in linkage equilibrium with index/
surrogate marker. Of the 44 European specific index SNPs, neither index nor surrogate SNPs were present for nine SNPs in
the genotyping array. Of the remaining 35, associations were replicated at seven genes namely PTPN22 (rs1217407,
p=3 610
23); IL2–21 (rs13119723, p=0.008); HLA-DRB1 (rs660895, p=2.56610
25; rs6457617, p=1.6610
209; rs13192471,
p=6.7610
216); TNFA1P3 (rs9321637, p=0.03); CCL21 (rs13293020, p=0.01); IL2RA (rs2104286, p=1.9610
24) and ZEB1
(rs2793108, p=0.006). Of the three Asian specific loci tested, rs2977227 in PADI4 showed modest association (p,0.02).
Further, of the 140 SNPs (in LE with index/surrogate variant) tested, association was observed at 11 additional genes: PTPRC,
AFF3, CD28, CTLA4, PXK, ANKRD55, TAGAP, CCR6, BLK, CD40 and IL2RB. This study indicates limited replication of European
and Asian index SNPs and apparent allelic heterogeneity in RA etiology among north Indians warranting independent
GWAS in this population. However, replicated associations of HLA-DRB1, PTPN22 (which confer ,50% of the heritable risk to
RA) and IL2RA suggest that cross-ethnicity fine mapping of such loci is apposite for identification of causal variants.
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Introduction
Genome wide association studies (GWAS) have enumerated
several new genes/loci for common-complex diseases. Better
insight into disease etiology arising from gene discovery via this
approach has further fuelled the hope that risk models based on
these findings will lead to personalized and preventive medicine
and also therapeutic interventions of complex diseases. Replica-
tions of GWAS findings across ethnic groups albeit with varying
effect sizes fortify this expectation.
Recent GWAS in rheumatoid arthritis (RA; MIM180300) have
unraveled disease susceptibility loci of small to moderate effect
size. Most of these genes/loci have risk alleles of known immune
function [1] justifying their involvement in RA which is a complex
autoimmune disorder characterized by chronic inflammation of
the synovial joints followed by progressive articular damage and
major functional disability [2]. Approximately 1% of the adult
population worldwide is affected by RA. However, the prevalence
varies from 0.2–0.3% in population from south-east Asia to 6% in
native American-Indian populations (i.e., Pima and Chippewa
Indians [3]) and women twice as likely to develop the disease as
men [2]. Findings from studies carried out in two Northern
European regions have suggested that approximately 60% of the
disease variance can be attributed to heritable factors [4]. Genetic
association studies have long implicated the human leukocyte
antigen locus DRB1 as the principle genetic factor conferring risk
to RA. In addition to HLA, GWAS carried out in European
populations have identified a total of 24 susceptibility genes/loci
(having 26 risk alleles) almost consistently associated with RA.
These include PTPN22, 6q23, TRAF1/C5, STAT4, IL2RB, KIF5A,
PRKCQ, IL2_IL21, CD226, CCL21, CD40, CTLA4, IL2RA, AFF3,
IL7R, BLK and c-Rel. Further, a recent GWAS using a meta-
analysis approach re-confirmed the importance of these 26 RA
risk alleles (Table S1) among Europeans [5]. The study also
identified seven new risk alleles conferring susceptibility to RA in
European ancestry. These SNPs are present in close proximity to
genes of known immune function, namely, IL6ST, SPRED2, RBPJ,
CCR6, IRF5 and PXK. However, HLA-DRB1 and PTPN22
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the effects of other genes are weak (odds ratio (OR) ,1.3). It is
noteworthy that while alleles at HLA-DRB1 locus, the largest
predisposing genetic risk factor to RA, has been associated with
RA among both Caucasian and Asian populations, not all
European specific RA susceptibility risk loci are associated among
Asians. The risk allele of SNP R620W in PTPN22 is monomorphic
in Asian ethnicity [7–8]. On the other hand, SNPs at Asian
specific RA loci i.e., PADI4, SLC22A4, and FCRL3 [9] showed
either modest or no association in the meta-analysis [5] and other
association studies reported in European populations [10–12].
These findings point towards genetic heterogeneity in RA
susceptibility across different ethnic groups.
RA is observed with same prevalence in the genetically distinct
north Indian population. Contribution of HLA locus to disease in
the population is well documented [13–14]. However, concrete
data on contribution of other candidate genes/loci are lacking.
Therefore, we investigated association status of RA risk conferring
genes/loci identified in European meta-analysis [5] in the
ethnically distinct north-Indian cohort using a two pronged
approach. Firstly, we carried out association analysis of 44 SNPs
from 40 candidate genes/loci (33 risk alleles with genome wide
significance i.e., p,10-8 and 11 moderate associations reported in
the European meta-analysis [5] and also three Asian specific genes
(PADI4, SLC22A4, and FCRL3) mentioned above. In the second
step, evidence for allelic/locus heterogeneity at aforementioned
genes/loci was assessed for by testing additional flanking SNPs in
linkage equilibrium with index/surrogate marker. The study
reports limited replication of European and Asian specific index
SNPs and apparent allelic heterogeneity in RA etiology among
north Indians.
Results
i) Replication of association of 47 index/surrogate SNPs
from 43 candidate genes/loci
a) SNPs reported in European population. Only 21 out of
the 44 European specific index SNPs (from 40 genes/loci) were
present in the SNP array used in this study. Of the remaining 23
SNPs, surrogates were identified for 14 index variants but none for
nine SNPs (rs10865035, rs10499194, rs5029937, rs3218253,
rs934734, rs6859219, rs13315591, rs874040, rs840016, and
rs7155603) [Table S1]. Despite the presence of index SNP
rs2476601 in PTPN22, but with its largely monomorphic status in
our cohort, a surrogate SNP rs1217407 was identified (and tested
for association). Associations (p,0.05) were replicated at only seven
loci namely PTPN22-rs1217407, IL2–21-rs13119723, HLA-DRB1-
rs6910071, TNFA1P3-rs9321637, CCL21-rs13293020, IL2RA-
rs2104286 and ZEB1-rs2793108. Although, the European meta-
analysis index SNP (rs6910071) from HLA-DRB1 showed
marginal association (p=0.046) in our cohort, further testing of
other SNPs from this gene (Table S1) revealed significant
association of three SNPs with RA in our population.
b) SNPs reported in Asian population. rs3761959 and
rs3753389 from FCRL3, and CD244 respectively were not
associated with RA in our cohort. Index SNP rs11203367 in
PADI4 was not present on the SNP array used in the study but the
surrogate SNP (rs2977227) showed association (p,0.02) with RA
(Table S1).
ii) Evaluation of allelic/genetic locus heterogeneity at 42
(39 European and 3 Asian) candidate genes/loci
a) 39 candidate genes/loci from European meta-
analysis. To evaluate allelic heterogeneity in the potential
candidate genes/loci, a total of 603 SNPs flanking index/surrogate
SNPs (selected based on LE) spanning across the 39 genes/loci
(excluding HLA) were tested (Table S1 and Table S2). Besides
significant associations at seven markers mentioned above,
associations (p,0.05) were observed with SNPs in 11 additional
genes namely, rs9803750 and rs2359952 (p,5610-4) in PTPRC;
rs17023158, rs6706188, and rs1437377 (p,5610-3) in AFF3;
rs4675367 (p,0.05) in CD28; rs231726 and rs10197319 (p=0.03)
in CTLA4; rs7622074 (p,0.02) and rs6767498 (p,0.005) in AFF3;
rs6877664 (p=0.016), rs10214316 (p=0.005), rs149140
(p=0.008) and rs32498 (p=0.006) in ANKRD55; rs926657
(p=0.003), rs9295089 (p=0.009), rs212402 (p=0.009) in
TAGAP; rs1331301 (p=0.01) and rs1556413 (p=0.02) in CCR6;
rs4841548 (p=0.03) and rs17806523 (p=0.009) in BLK;
rs6065925 (p,0.005) in CD40; and rs228942 (p,0.05) in IL2RB
(Table S1). In addition, two SNPs (rs3757173 and rs5029936) in
TNFA1P3 also showed stronger association (p,0.03) than the
surrogate SNP (p,0.05) (Table S1).
b) 3 candidate genes from Asian population. No
association of any SNP from the three Asian specific genes was
observed.
Thus of the 40 genes/loci showing disease association among
Europeans and of the three among Asians, replication was
observed at only 18 and one gene (PADI4) respectively in the
north Indian cohort. Further, of the above mentioned 19
associated markers only four SNPs withstood Bonferroni’s
correction (Table S1, Figure 1).
With 983 cases/1007 controls and after accounting for 173
comparisons (alpha set at 0.0003), the study had sufficient power
(80%) to detect associations with odds ratios 1.3 or higher (or 0.77
or lower) for allele frequencies between 20%,30%, odds ratios 1.4
or higher (0.71 or lower) for allele frequencies between 10%–20%
& odds ratios 1.6 or higher for allele frequencies of 5,10%
assuming a log-additive model of inheritance.
Figure 1. Quantile-Quantile plot of chi-square test of associa-
tion p-values of 48 SNPs (presented in Table S1).
doi:10.1371/journal.pone.0031584.g001
Status of RA Candidate Genes in North Indians
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Recent GWAS have identified 40 susceptibility genes/loci in
European and three in Asian populations that confer predisposi-
tion to RA (Table S1). Reported genetic associations but with
varying effect sizes and replicated across populations may reiterate
the importance of these genes in disease etiology independent of
the environmental attributes. Conversely, non-replication would
be an impetus for novel gene(s) discovery. Limited replication of
the CEU meta-analysis findings in RA among the ethnically
distinct north-Indian cohort in this study is noteworthy.
Replication of association of SNPs in HLA-DRB1, IL2–21 and
IL2RA (Table S1) clearly testify that the immune genes are major
and common players in RA across diverse ethnicities. HLA-DRB1
shared epitope (SE) acts as an immune-stimulatory ligand that can
direct T cell differentiation toward Th17 cells (that are) implicated
in the pathogenesis of autoimmune diseases, including RA [15].
Marginal association of the index SNP and strong association of
three other SNPs which have been shown to be strongly associated
with the disease in other Caucasian and Korean studies [6,16–17]
verify the importance of HLA-DRB1 in our cohort. IL2–21 and
IL2RA are cytokines with immuno-regulatory activity and are
considered general susceptibility loci for inflammatory diseases.
Another gene ZEB1 (found moderately associated (p=2610-3) in
European meta-analysis), believed to play a role in transcriptional
repression of IL2 pathway also showed significant association
(p=6610-3) in our study. Absence/marginal association of index/
surrogate SNPs but stronger association of flanking SNPs at RA
risk loci in our study cohort (Table S1) is suggestive of allelic
heterogeneity and warrants discussion.
Among the non-HLA markers, the mis-sense 620Arg.Trp
(rs2476601) variant in PTPN22 is the most strongly associated SNP
in various RA association studies performed in Caucasian
populations. The disease-associated allele (Trp) prevents the
interaction of the lymphoid protein tyrosine phosphatase (LYP)
with the T cell receptor-associated kinases. This may increase the
overall reactivity of the immune system thus predisposing an
individual to autoimmune disease. This SNP was largely
monomorphic (MAF,0.02) in our population in conformity with
the other reports from Asia [7–8]. However, unlike the results
from an extended analysis of the PTPN22 locus among Koreans
[8] which reported absence of association of any other SNP from
this gene, a significant association of rs1217407 (p=3.0610-3)
with RA was observed in our study (Table S1). Though, this may
be suggestive of allelic heterogeneity, significance of this intronic
SNP remains unexplained to date. Similarly significant association
of flanking SNPs were observed in PTPRC, AFF3, CD28, CTLA4,
PXK, ANKRD55, TAGAP, CCR6, BLK, CD40 and IL2RB believed
to have immuno-regulatory functions. Except for non-synonymous
polymorphism rs228942 (Asp391Glu) in IL2RB, other SNPs lie
either in the intronic or 39UTR region of the associated gene and
thus functional significance remain to be validated. Alternatively,
the associated SNP(s) may be in LD with another causal variant(s)
yet unidentified. These findings together suggest the role of all the
genes in RA among north-Indians but with likely heterogeneity
and varied effect sizes.
Failure to replicate association with the majority of genes/loci
reported from European ancestry is unlikely the result of Type II
error, given the sample size (n,1000 cases and 1000 controls
each) and more than 80% power therein to detect association at
moderate effect size. Second reason for non-replication could be
that the risk alleles reported in European populations may play a
role in susceptibility to RA only in the presence of certain
population specific and as yet unidentified environmental triggers/
diet/specific infectious agents. Alternatively, the index SNPs may
not be the causal SNPs, but could be in linkage disequilibrium with
the true disease causing SNPs on a haplotype that is found in the
European population but not in the north-Indian cohort. On the
other hand, our results may reflect true genetic heterogeneity
underlying RA. This hypothesis draws support from a recently
published article on comparative population architecture among
Indians and other HapMap populations [18]. A comparison of 55
diverse endogamous populations from India with CEU, YRI,
CHB, JPT populations (HapMap database) reflected the dissim-
ilarity/genetic heterogeneity among Caucasian (CEU), Asians
(CHB/JPT), and north-Indian populations. The principal com-
ponent analysis suggested that although the north-Indian popu-
lation shows maximum proximity to CEU as compared to all other
HapMap populations, they still form separate clusters. As for
population stratification in the study sample which may influence
genetic association results, every precaution was taken to carefully
match the controls and the patients based on age, sex, and self
reported ethnicity over the last three generations. Further, less
suitability of array design (poor tag transferability) due to
population specific LD patterns across susceptibility loci may
explain limited capture of causal variants in the north Indian
cohort. This possibility draws support from findings previously
reported from the lab for ulcerative colitis [19] and is reiterated in
this study. To illustrate this, a comparative LD profiles for
representative genes namely PTPRC and CD28 are shown in
Figures 2 & 3. Smaller LD blocks in our north-Indian (NI) cohort
as compared to CEU population are obvious in these LD plots.
In conclusion, our findings of poor/non-replication of European
GWAS hits in the north Indian cohort suggest differences in
genetic architecture between populations; they also reiterate that
in addition to common genetic risk factors, such as the HLA–
DRB1, there exist population specific genes involved in the etiology
of RA, necessitating GWAS in multiple ethnic groups. This is
supported by another recent study from our group reporting
limited replication of European findings in an Ulcerative colitis
cohort from north India [19]. These results emphasise the need for
finer/additional genome analysis of less investigated ethnic groups
which may greatly facilitate identification of novel genes besides
precise identification of disease causing variants in known genes.
Materials and Methods
Ethics Statement
The study was approved by the ethical committees of the
participating institutions (University of Delhi South Campus, New
Delhi; All India Institute of Medical Sciences, New Delhi;
Dayanand Medical College & Hospital, Ludhiana). Informed
written consent was obtained from all the subjects who
participated in this study. The study follows the recommendations
of the Declaration of Helsinki (2008).
RA and control subjects
Demographic Details: Ethnicity/Origin of individuals included
in the study cohort was ascertained by their language (mother
tongue) and geographical zone. The study cohort comprised of
subjects who are north-Indian (from the northern states of India
namely Jammu and Kashmir, Punjab, Haryana, Himachal
Pradesh, Uttaranchal, Uttar Pradesh, Bihar, Jharkhand, and
Madhya Pradesh) by ethnicity at least over the last three
generations.
A total of n=983 RA cases of north-Indian origin were
recruited from the All India Institute of Medical Sciences (AIIMS)
and Research and Referral Hospital (R&R), New Delhi based on
Status of RA Candidate Genes in North Indians
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were stored at 270uC and tested for sero-subtype of rheumatoid
factor (IgG, IgM and IgA) and anti-CCP antibodies (using
standard protocols) in one sitting after the recruitment of patients
was complete. C reactive protein (CRP), and erythrocyte
sedimentation rate (ESR) were also measured. N=1007 healthy
controls which included spouses and healthy staff members (above
35 years of age with no medical history of RA/or any other form
of arthritis) of north-Indian origin were recruited from the study
hospitals mentioned above and also from Dayanand Medical
College & Hospital, Ludhiana.
DNA extraction, Genotyping and Quality Control
DNA was collected from peripheral blood samples of RA
patients and control samples using conventional phenol-chloro-
form method. Genotyping was carried out using Infinium Human
660W-quad SNP microarray platform. The average genotyping
success rate was 99.98%. To this data we subsequently applied
Figure 2. A) LD plot of PTPRC among north-Indians, B) LD plot of PTPRC among CEU population, C) PTPRC haplotypes among north-Indians, D) PTPRC
haplotypes among CEU population.
doi:10.1371/journal.pone.0031584.g002
Figure 3. A) LD plot of CD28 among north-Indians, B) LD plot of CD28 among CEU population, C) CD28 haplotypes among north-Indians, D) CD28
haplotypes among CEU population.
doi:10.1371/journal.pone.0031584.g003
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included in the final analysis:
1. exclusion of SNPs with more than 5% of the values missing,
exclusion of individuals with more than 5% of genotyping
values missing (none), exclusion of SNPs with a minor allele
frequency (MAF) ,0.05, exclusion of SNPs failing Hardy
Weinberg Equilibrium test (p,0.0001).
2. Pi-HAT (pair-wise pi-Hat,0.2) test for relatedness was carried
out to exclude related individuals.
3. Multi-dimensional scaling (MDS) analysis was carried out to (i)
exclude outliers from the study cohort and (ii) to rule out
population stratification/genetic heterogeneity.
A total of 47 SNPs were initially selected for analysis in this
study. SNPs included were either index SNPs from the European
GWAS meta-analysis study [5] or their surrogates in LD (r2.0.8,
as seen in GIH Hap-Map Phase III population) when index SNPs
were not covered in the array used in the study. To preclude the
possibility of allelic/locus heterogeneity for such genes/loci,
additional SNPs in linkage equilibrium (LE) with index/surrogate
markers (based on GIH Hap-Map Phase III population) in
candidate genes/loci (Table S1), were analysed. Basic allelic
association test (which compares frequencies of alleles among case
and control groups) by chi-square test implemented in PLINK
[21] was performed to test association between a SNP and disease
(rheumatoid arthritis). To ascertain significance of association odds
ratio at 95% confidence interval was also calculated. Quanto
software was used to estimate power of the study (University of
South California, http://hydra.usc.edu/gxe). Odds ratios (OR)
considering a Bonferroni’s correction P-value of 0.0003 (for 173
comparisons) and different allele frequencies were calculated.
Supporting Information
Table S1 Association analysis of European specific RA
susceptibility genes/loci in north Indian cohort.
(DOC)
Table S2 Test of association of additional (flanking)
SNPs in European specific RA candidate genes/loci.
(DOC)
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